UCB SA (UCBJY)
149.57
-1.08
(-0.72%)
USD |
OTCM |
Oct 27, 16:00
UCB Max Drawdown (5Y) : 50.06% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 50.06% |
| August 31, 2026 | 50.06% |
| July 31, 2026 | 50.06% |
| June 30, 2026 | 50.06% |
| May 31, 2026 | 50.06% |
| April 30, 2026 | 50.06% |
| March 31, 2026 | 50.06% |
| February 28, 2026 | 50.06% |
| January 31, 2026 | 50.06% |
| December 31, 2025 | 50.06% |
| November 30, 2025 | 50.06% |
| October 31, 2025 | 50.06% |
| September 30, 2025 | 50.06% |
| August 31, 2025 | 50.06% |
| July 31, 2025 | 50.06% |
| June 30, 2025 | 50.06% |
| May 31, 2025 | 50.06% |
| April 30, 2025 | 50.06% |
| March 31, 2025 | 50.06% |
| February 28, 2025 | 50.06% |
| January 31, 2025 | 50.06% |
| December 31, 2024 | 50.06% |
| November 30, 2024 | 50.06% |
| October 31, 2024 | 50.06% |
| September 30, 2024 | 50.06% |
| Date | Value |
|---|---|
| August 31, 2024 | 50.06% |
| July 31, 2024 | 50.06% |
| June 30, 2024 | 50.06% |
| May 31, 2024 | 50.06% |
| April 30, 2024 | 50.06% |
| March 31, 2024 | 50.06% |
| February 29, 2024 | 50.06% |
| January 31, 2024 | 50.06% |
| December 31, 2023 | 50.06% |
| November 30, 2023 | 50.06% |
| October 31, 2023 | 50.06% |
| September 30, 2023 | 50.06% |
| August 31, 2023 | 50.06% |
| July 31, 2023 | 50.06% |
| June 30, 2023 | 50.06% |
| May 31, 2023 | 50.06% |
| April 30, 2023 | 50.06% |
| March 31, 2023 | 50.06% |
| February 28, 2023 | 50.06% |
| January 31, 2023 | 50.06% |
| December 31, 2022 | 50.06% |
| November 30, 2022 | 50.06% |
| October 31, 2022 | 50.06% |
| September 30, 2022 | 50.06% |
| August 31, 2022 | 46.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly & Co. | 34.47% |
| AstraZeneca PLC | 27.87% |
| Corcept Therapeutics, Inc. | 71.85% |
| Jazz Pharmaceuticals Plc | 47.55% |
| Novo Nordisk A/S | 74.70% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 7.042 |
| Beta (5Y) | 0.5899 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 31.68% |
| Historical Sharpe Ratio (5Y) | 0.4085 |
| Historical Sortino (5Y) | 0.6522 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 13.42% |